← All indications
Hypoplastic Left Heart Syndrome
A condition caused by underdevelopment of the whole left half of the heart. It is characterized by hypoplasia of the left cardiac chambers (HEART ATRIUM; HEART VENTRICLE), the AORTA, the AORTIC VALVE, and the MITRAL VALVE. Severe symptoms appear in early infancy when DUCTUS ARTERIOSUS closes.
Drugs by status
Phase 3 trials (1)
Phase 2 trials (10)
Phase 1 trials (6)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (22)
- Actelion
- Longeveron LLC
- The Dana Foundation
- National Institutes of Health (NIH)
- Aarhus University
- University of Pennsylvania
- Baylor University
- Harvard University
- Duke University
- New England Research Institutes
- Okayama University
- Translational Research Informatics Center, Kobe, Hyogo, Japan
- University of Oklahoma
- University of Toronto
- Mayo Clinic
- University of Copenhagen
- University of Utah
- University of Minnesota
- Cook Children's Medical Center
- University of Colorado
- The Mark H. and Blanche M. Harrington Foundation
- Children's Hospital Los Angeles
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (2)